Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes

Biochemical and Biophysical Research Communications

Volumn 415, Issue 1, 2011, Pages 200-205

  Takahashi, Nobuhiko ^a,b   Yoshizaki, Takayuki ^c   Hiranaka, Natsumi ^a   Suzuki, Takeshi ^a   Yui, Tomoo ^a   Akanuma, Masayasu ^a   Oka, Kazuya ^a   Kanazawa, Kaoru ^a   Yoshida, Mika ^a   Naito, Sumiyoshi ^a   Fujiya, Mikihiro ^b   Kohgo, Yutaka ^b   Ieko, Masahiro ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adipocyte; Adipose inflammation; Lipin 1; MCP 1; Obesity

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPIN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDES AND PROTEINS; QUINAZOLINE; SALICYLATE SODIUM; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN; CHEMOTAXIS; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; INSULIN RESISTANCE; METABOLISM; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CHEMOKINE CCL2; CHEMOTAXIS; GENE EXPRESSION; INSULIN RESISTANCE; MICE; NF-KAPPA B; NUCLEAR PROTEINS; OBESITY; PHOSPHATIDATE PHOSPHATASE; PROTEIN BIOSYNTHESIS; QUINAZOLINES; RNA, MESSENGER; RNA, SMALL INTERFERING; SALICYLATES;

EID: 80755188929     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.060     Document Type: Article

References (36)

1. Péterfy M., Phan J., Xu P., Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 2001, 27:121.
2. Donkor J., Sariahmetoglu M., Dewald J., Brindley D.N., Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J. Biol. Chem. 2007, 282:3450-3457.
3. 2+-dependent phosphatidate phosphatase enzyme. J. Biol. Chem. 2006, 281:9210-9218.
4. Phan J., Peterfy M., Reue K. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J. Biol. Chem. 2004, 279:29558-29564.
5. Koh Y.K., Lee M.Y., Kim J.W., Kim M., Moon J.S., Lee Y.J., Ahn Y.H., Kim K.S. Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2. J. Biol. Chem. 2008, 283:34896-34906.
6. Finck B.N., Gropler M.C., Chen Z., Leone T.C., Croce M.A., Harris T.E., Lawrence J.C., Kelly D.P. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 2006, 4:199-210.
7. Yao-Borengasser A., Rasouli N., Varma V., Miles L.M., Phanavanh B., Starks T.N., Phan J., Spencer H.J., McGehee R.E., Reue K., Kern P.A. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes 2006, 55:2811-2818.
8. van Harmelen V., Ryden M., Sjolin E., Hoffstedt J. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J. Lipid. Res. 2007, 48:201-206.
9. Croce M.A., Eagon J.C., LaRiviere L.L., Korenblat K.M., Klein S., Finck B.N. Hepatic lipin 1 expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes 2007, 56:2395-2399.
10. Suviolahti E., Reue K., Cantor R.M., Phan J., Gentile M., Naukkarinen J., Soro-Paavonen A., Oksanen L., Kaprio J., Rissanen A., Salomaa V., Kontula K., Taskinen M.R., Pajukanta P., Peltonen L. Cross-species analyses implicate lipin 1 involvement in human glucose metabolism. Hum. Mol. Genet. 2006, 15:377-386.
11. Donkor J., Sparks L.M., Xie H., Smith S.R., Reue K. Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J. Clin. Endocrinol. Metab. 2008, 93:233-239.
12. Chang Y.C., Chang L.Y., Chang T.J., Jiang Y.D., Lee K.C., Kuo S.S., Lee W.J., Chuang L.M. The associations of LPIN1 gene expression in adipose tissue with metabolic phenotypes in the Chinese population. Obesity 2010, 18:7-12.
13. Miranda M., Escote X., Alcaide M.J., Solano E., Ceperuelo-Mallafre V., Hernandez P., Wabitsch M., Vendrell J. Lpin1 in human visceral and subcutaneous adipose tissue: similar levels but different associations with lipogenic and lipolytic genes. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E308-E317.
14. Phan J., Reue K. Lipin, a lipodystrophy and obesity gene. Cell Metab. 2005, 1:73-83.
15. Tsuchiya Y., Takahashi N., Yoshizaki T., Tanno S., Ohhira M., Motomura W., Takakusaki K., Kohgo Y., Okumura T. A Jak2 inhibitor, AG490, reverses lipin-1 suppression by TNF-alpha in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2009, 382:348-352.
16. Takahashi N., Nagamine M., Tanno S., Motomura W., Kohgo Y., Okumura T. A diacylglycerol kinase inhibitor, R59022, stimulates glucose transport through a MKK3/6-p38 signaling pathway in skeletal muscle cells. Biochem. Biophys. Res. Commun. 2007, 360:244-250.
17. Youn B.S., Bang S.I., Kloting N., Park J.W., Lee N., Oh J.E., Pi K.B., Lee T.H., Ruschke K., Fasshauer M., Stumvoll M., Bluher M. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes 2009, 58:627-636.
18. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998, 396:77-80.
19. Tobe M., Isobe Y., Tomizawa H., Nagasaki T., Takahashi H., Fukazawa T., Hayashi H. Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappaB activation. Bioorg. Med. Chem. 2003, 11:383-391.
20. Grimsey N., Han G.S., O'Hara L., Rochford J.J., Carman G.M., Siniossoglou S. Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2. J. Biol. Chem. 2008, 283:29166-29174.
21. Peterfy M., Phan J., Reue K. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J. Biol. Chem. 2005, 280:32883-32889.
22. Baker R.G., Hayden M.S., Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011, 13:11-22.
23. Weisberg S.P. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
24. Xu H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
25. Takahashi K., Mizuarai S., Araki H., Mashiko S., Ishihara A., Kanatani A., Itadani H., Kotani H. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 2003, 278:46654-46660.
26. Bruun J.M., Lihn A.S., Pedersen S.B., Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 2005, 90:2282-2289.
27. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., Kadowaki T. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 2006, 281:26602-26614.
28. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116:1494-1505.
29. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., Ferrante A.W. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 2006, 116:115-124.
30. Skurk T., Alberti-Huber C., Herder C., Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 2007, 92:1023-1033.
31. Ito A., Suganami T., Miyamoto Y., Yoshimasa Y., Takeya M., Kamei Y., Ogawa Y. Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy. J. Biol. Chem. 2007, 282:25445-25452.
32. Kim H.B., Kumar A., Wang L., Liu G.H., Keller S.R., Lawrence J.C., Finck B.N., Harris T.E. Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol. Cell. Biol. 2010, 30:3126-3139.
33. Majeed H.A., Al-Tarawna M., El-Shanti H., Kamel B., Al-Khalaileh F. The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. Eur. J. Pediatr. 2001, 160:705-710.
34. Ferguson P.J., Chen S., Tayeh M.K., Ochoa L., Leal S.M., Pelet A., Munnich A., Lyonnet S., Majeed H.A., El-Shanti H. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J. Med. Genet. 2005, 42:551-557.
35. Zeharia A., Shaag A., Houtkooper R.H., Hindi T., de Lonlay P., Erez G., Hubert L., Saada A., de Keyzer Y., Eshel G., Vaz F.M., Pines O., Elpeleg O. Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am. J. Hum. Genet. 2008, 83:489-494.
36. Sun W., Yang J. Molecular basis of lysophosphatidic acid-induced NF-kappaB activation. Cell Signal. 2010, 22:1799-1803.